| Autor: |
Calvo-Arbeloa, María, Insausti-Serrano, Ana María, Arrondo-Velasco, Amaya, Sarobe-Carricas, María Teresa |
| Zdroj: |
Farmacia Hospitalaria; March 2020, Vol. 44 Issue: 2 p62-67, 6p |
| Abstrakt: |
Inflammatory bowel disease comprises a group of chronic relapsing inflammatory disorders affecting the bowel. In the last decade, the advent of biological drugs brought about a drastic change in the treatment of the disease. Adalimumab, golimumab and ustekinumab are three biologic agents that patients can self-administer subcutaneously after collecting them from the pharmacy department. However, for the treatment to be effective, adherence is paramount. The purpose of the present study is to evaluate adherence in patients who collected all three drugs from the dispensary of a tertiary care hospital. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
